[Federal Register Volume 81, Number 215 (Monday, November 7, 2016)]
[Notices]
[Pages 78158-78159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26830]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-0612]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Well-Integrated Screening and Evaluation for Women Across the
Nation (WISEWOMAN) Reporting System (OMB #0920-0612, exp. 12/31/2016)--
Extension--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The WISEWOMAN program (Well-Integrated Screening and Evaluation for
Women Across the Nation), sponsored by the Centers for Disease Control
and Prevention (CDC), was established to examine ways to improve the
delivery of services for women who have limited access to health care
and elevated risk factors for cardiovascular disease (CVD). The program
focuses on reducing CVD risk factors and provides screening services
for selected risk factors such as elevated blood cholesterol,
hypertension, and abnormal blood glucose levels. The program also
provides women with referrals to lifestyle programs and medical care.
The WISEWOMAN program provides services to women who are jointly
enrolled in the National Breast and Cervical Cancer Early Detection
Program (NBCCEDP), also administered by CDC.
The WISEWOMAN program is administered by state health departments
and tribal programs. In 2013, new cooperative agreements were awarded
under Funding Opportunity Announcement DP13-1302. These awards are
currently in the final year of funding, but may be extended by CDC for
one additional year, subject to the availability of funds.
CDC collects two types of information from WISEWOMAN awardees. The
hardcopy Annual Progress Report provides a narrative summary of each
awardee's objectives and the activities undertaken to meet program
goals. The estimated burden per response is 16 hours.
In addition, each WISEWOMAN awardee submits an electronic data file
to CDC twice per year. The Minimum Data Elements (MDE) file contains
de-identified, client-level information about the cardiovascular
disease risk factors of women served by the program, and the number and
type of lifestyle program sessions they attend. The estimated burden
per response for the MDE file is 24 hours.
CDC seeks a one-year extension to enable reporting for the final
year of activities funded under the current cooperative agreement and
the option year, subject to the availability of funds. There are no
changes to the information collected, the burden per response,
reporting frequency, the number of awardees, or the total annualized
burden hours.
CDC will continue to use the information collected from WISEWOMAN
awardees to support program monitoring and improvement activities,
evaluation, and assessment of program outcomes. The overall program
evaluation is designed to demonstrate how WISEWOMAN can obtain more
complete health data on vulnerable populations, promote public
education about disease incidence, cardiovascular disease risk-factors,
health promotion, improve the availability of screening and diagnostic
services for under-served women, ensure the quality of services
provided to underserved women, and develop strategies for improved
interventions. Participation in this information collection is required
as a condition of cooperative agreement funding. There are no costs to
respondents other than their time.
The total annualized burden hours are 1,344.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hrs.)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Awardees.................... Screening and Assessment 21 2 24
and Lifestyle Program
MDEs.
Annual Progress Report.. 21 1 16
----------------------------------------------------------------------------------------------------------------
[[Page 78159]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-26830 Filed 11-4-16; 8:45 am]
BILLING CODE 4163-18-P